A small study of iopofosine I 131 in patients with pretreated Waldenstrom’s macroglobulinemia showed that the disease control rate was 100%. Treatment with the novel CAR-T cell therapy was associated ...

"Fast Track designation for NX-5948 is an important recognition of the unmet patient need in Waldenstrom's macroglobulinemia, particularly in the growing number of patients whose cancer has progressed ...